FDA Inspection 649036 — Oklahoma Blood Institute

Oklahoma Blood Institute — FEI 3008629186

The FDA completed an inspection of Oklahoma Blood Institute on Feb 9, 2010 in Fort Smith, AR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 9, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fort Smith, AR (United States)

Citations

IDCFRDescription
6121 CFR 606.60(a)Provide proper equipment to meet requirements

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.